Publications - Released in 2020
The current HIV program is reaching KPs and PLHIV for prevention and treatment of HIV. The integrated intervention to KPs and providing HCV related activities like prevention, early diagnosis and providing treatment to cure HCV infection would be the cost-effective approach to decrease the burden of HCV among them. The availability of effective treatment – Direct - Acting Antiviral (DAA) has prevented HCV related consequences and cured from HCV infections. The pangenotypic DAA do not require genotyping of the virus and current WHO guidelines recommends that all HCV infected people are treated with minimal lab investigations and follow up. This recommendation helps us to combat Hep C related complications and prevent morbidities and mortalities and provide opportunity to treat clients at all kind of health facilities.
Downloads
Organizations
- National Centre for AIDS and STD Control (NCASC) - Nepal